Disc Medicine IncNASDAQ:IRON
- LAST PRICE48.1100
- TODAY'S CHANGE (%)-0.4700 (-0.9675%)
- Bid / Lots45.5700/ 1
- Ask / Lots77.5300/ 2
- Open / Previous Close48.3600 / 48.5800
- Day Range
- 52 Week Range
- Volume1,003,798
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IRON |
|---|---|---|
| 09:32 ET | 31807 | 48.36 |
| 09:52 ET | 100 | 48.87 |
| 09:59 ET | 400 | 48.68 |
| 10:01 ET | 100 | 48.165 |
| 10:06 ET | 100 | 48.16 |
| 10:08 ET | 200 | 47.875 |
| 10:10 ET | 100 | 47.955 |
| 10:12 ET | 200 | 47.895 |
| 10:14 ET | 200 | 47.895 |
| 10:15 ET | 300 | 47.245 |
| 10:17 ET | 200 | 47.36 |
| 10:19 ET | 100 | 47.36 |
| 10:21 ET | 300 | 47.54 |
| 10:24 ET | 406 | 47.545 |
| 10:28 ET | 200 | 47.68 |
| 10:33 ET | 113 | 47.715 |
| 10:35 ET | 100 | 47.705 |
| 10:42 ET | 300 | 47.72 |
| 10:48 ET | 100 | 47.72 |
| 10:50 ET | 846 | 47.8 |
| 10:57 ET | 100 | 47.89 |
| 11:00 ET | 252 | 48.03 |
| 11:04 ET | 103 | 47.62 |
| 11:08 ET | 100 | 47.855 |
| 11:11 ET | 421 | 47.62 |
| 11:15 ET | 803 | 47.72 |
| 11:20 ET | 100 | 47.675 |
| 11:24 ET | 100 | 47.725 |
| 11:26 ET | 100 | 47.68 |
| 11:27 ET | 200 | 47.855 |
| 11:36 ET | 100 | 47.53 |
| 11:45 ET | 209 | 47.685 |
| 11:49 ET | 200 | 47.78 |
| 11:56 ET | 100 | 47.71 |
| 12:00 ET | 100 | 47.58 |
| 12:03 ET | 600 | 47.8 |
| 12:07 ET | 100 | 47.785 |
| 12:09 ET | 600 | 47.88 |
| 12:12 ET | 100 | 47.785 |
| 12:16 ET | 600 | 47.76 |
| 12:23 ET | 417 | 47.82 |
| 12:27 ET | 100 | 47.795 |
| 12:30 ET | 200 | 47.735 |
| 12:34 ET | 205 | 47.84 |
| 12:41 ET | 1351 | 47.63 |
| 12:48 ET | 100 | 47.54 |
| 12:50 ET | 100 | 47.54 |
| 12:54 ET | 200 | 47.54 |
| 12:56 ET | 2413 | 47.51 |
| 12:57 ET | 100 | 47.55 |
| 01:01 ET | 500 | 47.56 |
| 01:03 ET | 100 | 47.505 |
| 01:06 ET | 105 | 47.45 |
| 01:10 ET | 700 | 47.55 |
| 01:15 ET | 1426 | 47.55 |
| 01:21 ET | 100 | 47.87 |
| 01:26 ET | 500 | 47.835 |
| 01:28 ET | 100 | 47.74 |
| 01:32 ET | 200 | 47.675 |
| 01:33 ET | 300 | 47.76 |
| 01:42 ET | 100 | 47.805 |
| 01:44 ET | 212 | 47.84 |
| 01:46 ET | 200 | 47.945 |
| 01:48 ET | 100 | 47.895 |
| 01:53 ET | 100 | 47.865 |
| 01:55 ET | 200 | 47.84 |
| 02:00 ET | 105 | 47.91 |
| 02:02 ET | 100 | 47.755 |
| 02:08 ET | 100 | 47.61 |
| 02:11 ET | 200 | 47.81 |
| 02:13 ET | 100 | 47.71 |
| 02:15 ET | 701 | 47.89 |
| 02:20 ET | 100 | 47.94 |
| 02:24 ET | 349 | 47.93 |
| 02:26 ET | 100 | 47.895 |
| 02:31 ET | 200 | 47.925 |
| 02:33 ET | 200 | 47.96 |
| 02:36 ET | 100 | 47.91 |
| 02:40 ET | 112 | 47.95 |
| 02:42 ET | 300 | 48.1 |
| 02:45 ET | 226 | 48.21 |
| 02:47 ET | 102 | 48.24 |
| 02:56 ET | 200 | 48.355 |
| 02:58 ET | 1000 | 48.16 |
| 03:00 ET | 400 | 48.095 |
| 03:02 ET | 608 | 48.125 |
| 03:03 ET | 200 | 48.075 |
| 03:05 ET | 200 | 47.795 |
| 03:07 ET | 500 | 47.9 |
| 03:09 ET | 300 | 47.83 |
| 03:12 ET | 800 | 47.89 |
| 03:14 ET | 200 | 47.85 |
| 03:16 ET | 100 | 47.835 |
| 03:18 ET | 100 | 47.85 |
| 03:20 ET | 100 | 47.845 |
| 03:21 ET | 625 | 47.935 |
| 03:23 ET | 325 | 48.06 |
| 03:25 ET | 454 | 48.055 |
| 03:27 ET | 100 | 48.135 |
| 03:30 ET | 490 | 48.19 |
| 03:32 ET | 100 | 48.195 |
| 03:34 ET | 125 | 48.23 |
| 03:38 ET | 903 | 48.22 |
| 03:39 ET | 800 | 48.205 |
| 03:45 ET | 200 | 48.21 |
| 03:48 ET | 100 | 48.205 |
| 03:50 ET | 1369 | 48.16 |
| 03:52 ET | 4222 | 48.57 |
| 03:54 ET | 2967 | 48.6 |
| 03:56 ET | 2940 | 48.48 |
| 03:57 ET | 1636 | 48.12 |
| 03:59 ET | 683122 | 48.11 |
Today
Yesterday
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caff , MD as Chief Regulatory Officer, from 8:30AM ET on Thursday Sep 19, 2024 by Dow Jones
8:30AM ET on Thursday Sep 19, 2024 by Dow JonesPress Release: Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caff , MD as Chief Regulatory Officer, from 8:30AM ET on Thursday Sep 19, 2024 by Dow Jones
8:30AM ET on Thursday Sep 19, 2024 by Dow Jones
Sep 16, 2024
DJ Disc Medicine Price Target Maintained With a $70.00/Share by HC Wainwright & Co., from 8:01AM ET on Monday Sep 16, 2024 by Dow Jones
8:01AM ET on Monday Sep 16, 2024 by Dow Jones
Aug 30, 2024
Disc Medicine to Participate in Upcoming Investor Conferences, from 8:00AM ET on Friday Aug 30, 2024 by Dow Jones
8:00AM ET on Friday Aug 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Disc Medicine Inc | 1.4B | -13.1x | --- |
ARS Pharmaceuticals Inc | 1.4B | -31.7x | --- |
Cassava Sciences Inc | 1.5B | -73.5x | --- |
Belite Bio Inc | 1.5B | -39.5x | --- |
NewAmsterdam Pharma Company NV | 1.4B | -6.0x | --- |
Spyre Therapeutics Inc | 1.5B | -2.0x | --- |
Company Information
Disc Medicine, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps) including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.
Contact Information
- Headquarters
- 321 Arsenal Street, Suite 101WATERTOWN, MA, United States 02472
- Phone
- 617-674-9274
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Donald Nicholson
- President, Chief Executive Officer, Director
- John Quisel
- Chief Financial Officer, Treasurer
- Jean Franchi
- Chief Operating Officer
- Jonathan Yu
- General Counsel
- Rahul Khara
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.59 |
EPS | $-3.66 |
Book Value | $14.17 |
P/E Ratio | -13.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
